Profound Medical Launches Real-Time iMRI Software to Boost TULSA Procedure Efficiency
Event summary
- Profound Medical introduced new Treatment Delivery Console (TDC) software for its TULSA-PRO system on August 17, 2026.
- The software enhances real-time iMRI control and improves user interface for prostate ablation procedures.
- Current TULSA physicians report performing up to four procedures per day, with potential to reach six procedures per day with the new software.
- TULSA-PRO leverages supervised robotic autonomy, contrasting with competitive 'master-slave' robotic systems.
The big picture
Profound Medical's new TDC software positions the company to capitalize on the growing demand for minimally invasive prostate treatments. The shift towards supervised robotic autonomy aligns with broader industry trends toward AI-driven precision medicine. The software's potential to increase procedural efficiency could accelerate TULSA-PRO's market penetration, particularly as it competes with traditional surgical and radiation therapies.
What we're watching
- Procedural Efficiency
- How the new TDC software will impact the pace of TULSA Procedure adoption and scalability.
- Competitive Advantage
- Whether Profound's supervised robotic autonomy will sustain its market differentiation.
- Regulatory Expansion
- The pace at which Profound can secure additional regulatory approvals for TULSA-PRO in new markets.
Related topics